“THESE CHIMERIC GENES HOLD PROMISE FOR THE
IMMUNOTHERAPY OF CANCER.” – Dr Zelig Eshhar 1989
CAR-T therapy is a revolutionary new cancer treatment option but its development has been decades in the making …
2017
In 2017 CAR-T therapy was named Advance of the Year by the American Society for Clinical Oncology.
Also in 2017, the FDA approved for use two CAR-T cell therapies to treat children and young adults with ALL and adults with diffuse large B-cell lymphoma.
